Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

S S Franklin1, S A Khan, N D Wong

  • 1Heart Disease Prevention Program, University of California, Irvine, USA. sfrankln@ucla.edu

Circulation
|July 27, 1999
PubMed

Insights

Pulse pressure (PP) provides valuable information for predicting coronary heart disease (CHD) risk in older adults. Higher PP, especially with lower diastolic blood pressure (DBP) at higher systolic blood pressure (SBP) levels, indicates increased CHD risk.

Area of Science:

  • Cardiology
  • Epidemiology
  • Hypertension Research

Background:

  • Current hypertension definitions rely on systolic blood pressure (SBP) and diastolic blood pressure (DBP), omitting pulse pressure (PP).
  • The predictive value of PP for coronary heart disease (CHD) risk remains under-examined in population-based studies.

Purpose of the Study:

  • To investigate whether pulse pressure (PP) offers additional predictive information for coronary heart disease (CHD) risk beyond traditional blood pressure measures.
  • To assess the independent and combined contributions of SBP, DBP, and PP in predicting long-term CHD risk.

Main Methods:

  • Analysis of 1924 participants aged 50-79 from the Framingham Heart Study, free of CHD and antihypertensive medication at baseline.
  • Utilized Cox regression over a 20-year follow-up, adjusting for age, sex, and other cardiovascular risk factors.
  • Examined individual and joint associations of SBP, DBP, and PP with incident CHD events.

Main Results:

  • Individually, SBP, DBP, and PP were associated with CHD risk, with PP showing the strongest association (largest chi(2) statistic).
  • When SBP and DBP were analyzed together, SBP remained a positive predictor (HR 1.22), while DBP showed a negative association (HR 0.86).
  • In subgroups, higher PP consistently predicted increased CHD risk, particularly when DBP was low at elevated SBP levels (SBP ≥ 120 mm Hg).

Conclusions:

  • Pulse pressure (PP) is a significant independent predictor of coronary heart disease (CHD) risk in middle-aged and elderly individuals.
  • Lower diastolic blood pressure (DBP) at higher systolic blood pressure (SBP) levels (SBP ≥ 120 mm Hg) is associated with increased CHD risk, highlighting the importance of PP.
  • Neither SBP nor DBP alone is superior to PP in predicting CHD risk, suggesting PP should be considered in cardiovascular risk assessment.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...